{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:46:29Z","timestamp":1772196389931,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.129","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T10:52:28Z","timestamp":1234003948000},"page":"2138-2143","source":"Crossref","is-referenced-by-count":12,"title":["Poly(lactide-co-glycolide) microspheres: A potent oral delivery system to elicit systemic immune response against inactivated rabies virus"],"prefix":"10.1016","volume":"27","author":[{"given":"R.","family":"Ramya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.K.","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.D.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Madhanmohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.R.","family":"Kannaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sridevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Anukumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.01.129_bib1","unstructured":"WHO Expert Consultation on Rabies. World Health Organization. Technical Report Series 2005;931:1\u201388."},{"key":"10.1016\/j.vaccine.2009.01.129_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-1135(90)90156-P","article-title":"Oral immunization of foxes with avirulent rabies virus mutants","volume":"23","author":"LeBlois","year":"1990","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2009.01.129_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/354520a0","article-title":"Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine","volume":"354","author":"Brochier","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.01.129_bib4","first-page":"49","article-title":"Rabies virus vaccines","volume":"84","author":"Schneider","year":"1995","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2009.01.129_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7589\/0090-3558-28.4.629","article-title":"Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores","volume":"28","author":"Rupprecht","year":"1992","journal-title":"J Wildlife Dis"},{"key":"10.1016\/j.vaccine.2009.01.129_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0264-410X(94)90003-5","article-title":"Potential of polymer microencapsulation technology for vaccine innovation","volume":"12","author":"Morris","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.129_bib7","series-title":"Drug carriers in biology and medicine","first-page":"237","article-title":"Lactic\/glycolic acid polymers","author":"Wise","year":"1979"},{"key":"10.1016\/j.vaccine.2009.01.129_bib8","first-page":"191","article-title":"Vaccine-containing biodegradable microspheres specifically enters the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response","volume":"25","author":"Eldridge","year":"1989","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2009.01.129_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0161-5890(91)90076-V","article-title":"Biodegradable microspheres as a vaccine delivery system","volume":"28","author":"Eldridge","year":"1991","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2009.01.129_bib10","first-page":"91","article-title":"Immune responses to influenza virus in orally and systematically immunized mice","volume":"146","author":"Moldoveanu","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.01.129_bib11","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1128\/JVI.75.19.9037-9043.2001","article-title":"Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines","volume":"75","author":"O\u2019Hagan","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.01.129_bib12","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/j.vaccine.2006.01.011","article-title":"Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally","volume":"24","author":"Jaganathan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.129_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-1157(88)90026-1","article-title":"The preparation of cultured rabies virus and the production of antiserum for human use","volume":"16","author":"Consales","year":"1988","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2009.01.129_bib14","series-title":"Laboratory techniques in rabies","first-page":"234","article-title":"b-Propiolactone-inactivated sheep brain vaccine","author":"Singh","year":"1996"},{"key":"10.1016\/j.vaccine.2009.01.129_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.129_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/JVI.21.2.626-635.1977","article-title":"Induction and biological properties of defective interfering particles of rabies virus","volume":"21","author":"Wiktor","year":"1977","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.01.129_bib17","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/S0264-410X(01)00192-X","article-title":"Biodegradable PLG A microspheres as a delivery system for malaria synthetic peptide SPf 66","volume":"19","author":"Rosas","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.129_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0264-410X(98)00229-1","article-title":"The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticle based on blends of lactide polymers and polyethylene glycol","volume":"17","author":"Lavelle","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.129_bib19","series-title":"Laboratory techniques in rabies","first-page":"417","article-title":"Potency test for antirabies serum and immunoglobulin","author":"Fitzgerald","year":"1996"},{"key":"10.1016\/j.vaccine.2009.01.129_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2009.01.129_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-1-23","article-title":"Field trail with oral vaccination of dogs against rabies in the Philippines","volume":"1","author":"Estrada","year":"2001","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.129_bib22","first-page":"207","article-title":"A bait delivery system suitable for oral rabies vaccine for stray dogs in India","volume":"75","author":"Jayakumar","year":"1998","journal-title":"Indian Vet J"},{"key":"10.1016\/j.vaccine.2009.01.129_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/oxfordjournals.aje.a121283","article-title":"Oral vaccination of foxes against rabies","volume":"93","author":"Baer","year":"1971","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.01.129_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/0264-410X(93)90313-M","article-title":"Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system","volume":"11","author":"O\u2019Hagan","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.129_bib25","series-title":"New generation vaccines","first-page":"215","article-title":"Prospects for the development of new and improved vaccines through the use of microencapsulation technology","author":"O\u2019Hagan","year":"1997"},{"key":"10.1016\/j.vaccine.2009.01.129_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4049\/jimmunol.121.1.321","article-title":"The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells","volume":"121","author":"Miller","year":"1978","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.129_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/IAI.31.1.297-308.1981","article-title":"Mouse model for abortive rabies infection of the central nervous system","volume":"31","author":"Smith","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.129_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1348-0421.1981.tb00094.x","article-title":"Essential role of T cells in the post-exposure prophylaxis of rabies in mice","volume":"25","author":"Mifune","year":"1981","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.01.129_bib29","doi-asserted-by":"crossref","first-page":"9165","DOI":"10.1073\/pnas.84.24.9165","article-title":"Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein","volume":"84","author":"Dietzschold","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.01.129_bib30","series-title":"Immunology of the nervous system","author":"Leibowitz","year":"1983"},{"key":"10.1016\/j.vaccine.2009.01.129_bib31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/0264-410X(95)00084-E","article-title":"Synthetic delivery systems for tuberculosis vaccines: Immunological evaluation of the M. tuberculosis 38kDa protein entrapped in biodegradable microparticles","volume":"13","author":"Vordermeier","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.129_bib32","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0264-410X(95)00184-3","article-title":"Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+cytotoxic T lymphocytes and CD4+TH1 cells","volume":"13","author":"Moore","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.129_bib33","first-page":"243","article-title":"A phagosome to cytosol pathway for exogenous antigens presented on MHC class I molecules","volume":"267","author":"Kovacsovics-Bankowski","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.01.129_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0042-6822(87)90167-X","article-title":"Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies","volume":"161","author":"Dietzschold","year":"1987","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T22:27:29Z","timestamp":1684880849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09001996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":34,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09001996"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.129","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}